Apolipoprotein J (ApoJ) may inhibit the ubiquitination of mTOR by FBW7 in NAFLD, resulting in mTOR activation, suppression of lipophagy and lysosomal function, and the occurrence and progression of NAFLD (51). Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.